Skip to the content

Penn State Health St. Joseph Awarded Reaccreditation from Commission on Cancer

Penn State Health St. Joseph Awarded Reaccreditation from Commission on Cancer

Reading, Pa. –  Penn State Health St. Joseph has earned a three-year accreditation from the American College of Surgeons Commission on Cancer (CoC) after a comprehensive onsite review by the organization in July.

The purpose of the award is to recognize those cancer programs that achieve excellence in meeting CoC standards and to encourage cancer programs to continually ‘raise the bar’ on quality cancer care in their communities. St. Joseph’s cancer program is evaluated every three years by the CoC on 34 standards of performance. The standards include leadership, clinical services, patient outcomes, and data quality and data management.

CoC Accreditation benefits St. Joseph’s patients by ensuring that they have access to leading edge services and equipment, a multidisciplinary approach to treatment, clinical trials and new treatment options, and access to prevention and early detection programs.

“We are honored to be recognized for our service to the community,” Oncologist Dr. Marc Rovito, Assistant Professor of Medicine, Penn State College of Medicine, and Medical Director of St. Joseph’s Cancer Center.  “This accreditation further confirms that our patients are getting the world-class cancer care of an academic medical center close to home.”  St. Joseph’s Oncology providers are members of the Penn State Cancer Institute, at Penn State Milton S. Hershey Medical Center, but they practice full-time in the Cancer Center on St. Joseph’s Bern Township campus.

“The CoC re-accreditation is strong acknowledgement of the quality of our program and the dedication of our physicians, nurses and clinical staff to providing compassionate care to our cancer patients and their families,” added Karen Wagner, Director of Oncology Services.